IFN-alpha 1 Antibody - Humanized, (Research Grade rontalizumab Biosimilar) - Low Endotoxin, Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28270
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Format
Concentration
Product Specifications
Immunogen
Clonality
Host
Isotype
Endotoxin Level
Description
Also known as 'rontalizumab'.
This product is shipped at ambient temperature. Upon receipt, store immediately at -20C or lower for 12 months in a lyophilized state. - 80C for 3 months after reconstitution. Avoid repeated freeze-thaw cycles.
Applications
ELISA
Flow Cytometry
Functional
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Format
Preservative
Concentration
Shipping
Stability & Storage
Background: IFN-alpha 1
Interferon-alpha (IFN-alpha), also known as leukocyte interferon, represents a group of related but distinct proteins that share over 95% amino acid sequence homology. They are members of the type I interferon family which share a common cell surface receptor composed of two subunits, a 100 kDa ligand-binding subunit (IFN-alpha R2) and a 125 kDa ligand binding and signal transduction subunit (IFN-alpha R1) that is involved both in ligand binding and signal transduction. IFN-alpha has both anti-viral and immunomodulatory activities on target cells.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional IFN-alpha 1 Products
Product Specific Notices
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.